Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.
Unlocked develops medical foods powered by our proprietary active ingredients: enzyme‑rich, shelf‑stable postbiotics.
Perfuiso markets an FDA cleared non-invasive surgical imaging device.
Rhealth is a biotechnology company that provides health management solutions based on advanced AI through a platform to hospitals.
Rendever is a research-based virtual reality platform that provides cognitive stimulation, socialization, and therapy for older adults.
Efemoral Medical is a medical technology company developing treatment solutions for patients suffering from peripheral vascular disease.
Anavasi Diagnostics is a medical technology company that focuses on the development of molecular diagnostic testing.
Trace Matters is a technology startup focused on developing next generation of mass spectrometry technologies for a variety of applications.
Hackensack Meridian Health is a health care organization that offers research and medical services.
BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control, and repair peripheral nerves.
Biotechnology company inspired by globin chemistry and protein engineering focused on developing breakthrough antidotal therapies.
GreenMark is a healthcare company providing health-based benefits using nanoparticles.
Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.
4E Therapeutics is a neuroscience company that develops therapies for chronic neuropathic pain.
Rhaeos is a medical device company that develops wearable sensors to improve the treatment of chronic health conditions.
Neuronoff is a medical device developing comapny.
RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.
Averto Medical is a medical device manufacturing company.
Georgia CTSA is an alliance that offers compelling, unique, and synergistic advantages to research and patients statewide.
HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.
A digital health platform that uses analysis of eye-movements as a biomarker to assess brain health across neurological disorders.
Neurodon is a biopharmaceutical company with small molecules in IND-enabling studies for type 1 and type 2 diabetes and Alzheimer's disease.
Burst Diagnostics engages in the future of at-home and point-of-care testing.
Brixton Biosciences is a clinical-stage life sciences company that develops therapies for chronic and acute pain.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical Device, Medical, Manufacturing. The firm invests across 24 different industry categories.
Among tracked funding rounds, ProLynx received $70.0M in a Series A round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include ProLynx, Unlocked Labs, Perfusio, Rhealth, Rendever. These companies were founded in 2020 or later.